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Abstract
AIM—The present study examined the Patient Reported Outcomes Measurement Information 
System (PROMIS) Mobility, Fatigue, and Pain Interference Short Forms (SFs) in children and 
adolescents with cerebral palsy (CP) for the presence of differential item functioning (DIF) 
relative to the original calibration sample.
METHOD—Using the Graded Response Model we compared item parameter estimates generated 
from a sample of 303 children and adolescents with CP (175 males, 128 females; mean age 15y 
5mo) to parameter estimates from the PROMIS calibration sample, which served as the reference 
group. DIF was assessed in a two-step process using the item response theory–likelihood ratio–
differential item functioning detection procedure.
RESULTS—Significant DIF was identified for four of eight items in the PROMIS Mobility SF, 
for two of eight items in the Pain Interference Scale, and for one item out of 10 on the Fatigue 
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SUPPORTING INFORMATION
The following additional material may be found online:
Table SI: Mobility Short Form: item-level descriptive statistics.
Table SII: Mobility Short Form: S-X2 item-level diagnostic statistics.
Table SIII: Fatigue Short Form: item-level descriptive statistics.
Table SIV: Fatigue Short Form: S- X2 item-level diagnostic statistics.
Table SV: Pain Interference Short Form: item-level descriptive statistics.
Table SVI: Pain Interference SF: S- X2 item-level diagnostic statistics.
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Scale. Impact of DIF on total score estimation was notable for Mobility and Pain Interference, but 
not for Fatigue.
INTERPRETATION—Results suggest differences in the responses of adolescents with CP to 
some items on the PROMIS Mobility and Pain Interference SFs. Cognitive interviews about the 
PROMIS items with adolescents with varying degrees of mobility limitations would provide better 
understanding of how they are interpreting and selecting responses to the PROMIS items and thus 
help guide selection of the most appropriate way to address this issue.
The Patient Reported Outcomes Measurement Information System (PROMIS) was 
developed to support measurement of health-related quality of life for children, adolescents, 
and adults. Each domain consists of item response theory (IRT) calibrated item banks, in 
which items are hierarchically organized from low to high levels of the respective ability or 
symptom experience. PROMIS measures may be administered either as computerized 
adaptive tests or as brief, fixed-length Short Forms (SFs) consisting of eight to 10 items that 
span the continuum of the latent trait being assessed.
PROMIS instruments use an approach to measurement that is domain-specific, rather than 
disease- or condition-specific.1 Items were designed to capture the common components of a 
concept on the assumption that these are relevant regardless of one’s condition. This 
approach rests on the expectation that the items in the instrument measure the same 
underlying trait (latent trait) regardless of the patient population responding to them. 
However the PROMIS developers also acknowledge the need for continuing validation 
research to examine whether the measures perform equally well in different clinical groups, 
thus yielding a valid and generalizable assessment from a single, general set of item 
parameters.1, 2 Two related validity issues need to be considered. First, are the items equally 
appropriate for all clinical groups? Second, do those items show measurement invariance? 
Measurement invariance refers to the expectation that the likelihood of an item response 
from two people at the same level of the latent trait does not differ depending on their group 
membership. This issue is especially relevant in clinical populations where the measurement 
construct reflects an area of primary impairment or symptom experience. These impairments 
or experiences may alter the difficulty of the activities relative to one another, and therefore 
lead to different item performance for participants with the same ability level on the 
underlying trait, resulting in differential item functioning (DIF).
The PROMIS pediatric Mobility, Fatigue, and Pain Interference item banks were calibrated 
in a sample of more than 4000 children, of whom 28% reported at least one chronic medical 
condition.3–5 However, the most common conditions were asthma (18% of sample), 
attention-deficit disorder/attention-deficit–hyperactivity disorder (4.6%), and arthritis, 
gastrointestinal disorders, mental disorders, immune disorders, and allergies (1–3% each).4 
There were few participants with physically-disabling chronic conditions such as cerebral 
palsy (CP). Because the impact of CP on daily life may be quite different, it is important to 
evaluate measurement invariance in this population. The present study compared item 
parameters for the Mobility, Fatigue, and Pain Interference SF items derived from PROMIS 
calibration samples to item parameter estimates from children and adolescents with CP. 
Specific research questions were as follows. Are the PROMIS pediatric SF item parameter 
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estimates for these SFs equivalent across the PROMIS calibration sample and children and 
adolescents with CP? If item parameter estimates differ, how much do these differences 
affect IRT-based summary scores for children and adolescents with CP?
METHOD
Participants
Participants with CP were a combined sample of children and adolescents who had 
completed the three SFs in two studies described below.
The first CP sample (n=113) was from a study examining responsiveness of PROMIS 
measures following elective musculoskeletal surgery.6 PROMIS SF data from the baseline 
assessment (pre-surgery) of a sample (aged 8–21y) with a confirmed diagnosis of CP was 
used. Exclusion criteria were: orthopedic surgery for reason other than to improve physical 
functioning; cognitive impairment that limited the child’s ability to read, understand, and 
respond to items; primary language other than English; and functional limitations caused by 
meningitis, brain tumors, or acquired injuries, and/or disease of the brain.
The second CP sample (n=190) was obtained from a study of children, adolescents, and 
young adults (aged 14–25y) to develop a scoring link between pediatric and adult PROMIS 
item banks.7 Inclusion criteria included the ability to understand and respond (speaking, 
using a communication board, or gesturing) to self-report questions, and CP diagnosis 
confirmed through medical record review. Each site participating in these two studies 
obtained local Institutional Review Board approval.
PROMIS sample calibration estimates were obtained from the PROMIS project. Estimates 
were derived from a large-scale study conducted in two states, North Carolina and Texas, 
described in detail in previous publications.4, 5 Participants aged 8 to 17 years were recruited 
from outpatient pediatric and specialty clinics, and public school settings. Participants 
(including the consenting parent or guardian) needed to be able to speak and read English 
and the adolescent needed to be able to see and interact with a computer screen, keyboard, 
and mouse.
All procedures performed in studies involving human participants were in accordance with 
the ethical standards of the institutional and/or national research committee and with the 
1964 Helsinki Declaration and its later amendments or comparable ethical standards. 
Informed consent was obtained from all individual participants included in the study.
Procedure
Participants aged 18 years or older provided informed consent. Participants in sample 1 used 
a tablet computer to complete the PROMIS measures via the Assessment Center platform 
(Department of Medical Social Sciences, Northwestern University, Chicago, IL).8 A study 
team member remained in the room with the participant in case any questions or problems 
arose. Sample 2 participants completed the measures in interview format, either in person or 
over the phone. Color-coded response cards were provided to ensure that participants were 
referencing the appropriate response set for each item, and all responses were entered 
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directly into the Assessment Center platform. All data collectors completed a standardized 
webinar-based training process and followed a detailed manual of procedures.
Participants in the PROMIS calibration study completed the instruments on laptop 
computers without parent or peer assistance. Each child completed one of seven different 
administration forms, thus different numbers of children completed particular items within 
each domain.
Instruments
All participants completed the Mobility (eight items), Pain Interference (eight items), and 
Fatigue (10 items) SFs. The measures use a common context: ‘In the past 7 days…’ 
followed by a specific item stem and five response options: ‘with no trouble’, ‘a little 
trouble’, ‘some trouble’, ‘a lot of trouble’, ‘unable to do’ (Mobility), where higher scores 
indicate better mobility function; and ‘never’, ‘almost never’, ‘sometimes’, ‘often’, ‘almost 
always’ (Fatigue; Pain Interference), where higher scores indicate more pain or fatigue. All 
measures were normed on the PROMIS pediatric calibration samples and are scored on a T 
metric with a mean of 50 and standard deviation (SD) of 10.
The Gross Motor Function Classification System – Expanded and Revised version (GMFCS 
– E&R)9, 10 was used to describe the severity of participants’ mobility limitations.
Data analysis
The marginal maximum likelihood estimation method was applied using IRTPRO (Scientific 
Software International Inc., Skokie, IL) to calibrate the items. We selected the Graded 
Response Model to fit the items, which has been commonly used in PROMIS calibration. 
The Graded Response Model uses a slope parameter and a number of threshold parameters 
to characterize the item response. The slope parameter (discrimination parameter) describes 
the strength of association between the item response and the latent trait. Because all items 
were recoded with the same direction (higher score indicates greater function), a higher 
slope in this study indicates that the item can discriminate more clearly between respondents 
with more or less of the trait. The threshold parameter represents the value on the latent trait 
where a participant will have 50% probability of responding with this rating or higher.
Before conducting DIF analyses, we applied confirmatory factor analysis to evaluate 
whether items in each scale fit a unidimensional model in the CP sample.
DIF analyses were conducted using the methodology outlined in other PROMIS studies.11 
To assess DIF across the two groups, we applied a two-step IRT-based method using the 
PROMIS calibration sample data as the reference group and CP data as the focal group. In 
the first step, we constrained the mean and SD of the PROMIS sample by setting them to 0 
and 1 respectively. We then set the item parameters to be equal across the two samples to 
estimate the mean and SD of the CP sample. We next fixed the CP sample mean and SD and 
free estimated the item parameters across the two samples. The Wald χ2 test was used to 
examine the equality of item parameters (including discrimination and threshold) across 
groups and identify DIF items. Because this method for DIF detection requires multiple tests 
of significance, we applied the Benjamini–Hochberg adjustment6, 12 to control for Type 1 
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error in multiple comparisons. Items without DIF identified in this step were used as anchor 
items in the next step. In the second step, we constrained the non-DIF item parameters to be 
equal across the two samples, free estimated the mean and SD for the CP sample and the 
parameters of the rest of the items, and examined DIF using a two-group IRT model.13, 14
Graphical methods were used to evaluate the magnitude of effect sizes when significant DIF 
was detected.13 For items that exhibited DIF (i.e. parameters were significantly different), 
we visually examined Item Characteristic Curves (ICC) and Option Characteristic Curves to 
identify trends. First, we examined whether the DIF was uniform or non-uniform. For 
uniform DIF, we evaluated whether the item was easier or harder in the CP sample compared 
to the PROMIS sample. For non-uniform DIF we identified the score range in which the 
item became easier or harder, and trends of items that were easier or harder relative to the 
PROMIS estimates. We determined the DIF impact by calculating the weighted area 
between the expected score curves (wABC).15 For items that include five response options, 
wABC greater than 0.3 suggests possible problematic DIF and need for further investigation. 
Finally, to examine DIF impact at the score level, we calculated two summed scores based 
on the IRT score: one based on the item parameters generated from the sample; and the other 
based on the item parameters generated from the CP sample. Item parameters were set to be 
equal in DIF-free items. In calculating the IRT score, the CP sample distribution was set as 
the target population.
We also examined DIF by sex and age groups (<18y; ≥18y).
RESULTS
Compared to the PROMIS calibration sample, the sample with CP included a higher 
percentage of males and had a higher mean age. Children and adolescents in the CP sample 
had a range of mobility limitations, with a greater representation at higher levels of 
functioning according to GMFCS. More than 80% of the participants with CP were 
ambulatory, although with some degree of limitation, and 16% of this group used some form 
of device when walking (Table I for details of both samples).
Results of confirmatory factor analysis supported the unidimensionality of the three scales in 
the CP sample: Fatigue, M2=1050.25, root mean square error of approximation 
(RMSEA)=0.04; Pain Interference, M2=806.99, RMSEA=0.05; and Mobility, M2=638.6, 
RMSEA=0.04.
There was no DIF by either age group or sex in the CP sample.
Mobility SF
Mean scores of the CP sample on individual Mobility SF items were consistently lower than 
item means in the PROMIS calibration sample, although the size of the difference varied 
(range=0.08–1.43).
The first step of the DIF analysis revealed six out of eight items with significant DIF. In step 
2, parameters for the items without DIF were constrained to be equivalent, and the parameter 
estimates were again compared. Results showed that all six items continued to display 
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significant DIF. Among the six statistically significant DIF items, there were four items with 
a wABC value (weighted by the CP sample distribution) that exceeded the 0.3 criterion 
(Table II). If the PROMIS Mobility SF item parameters were used to score the CP sample, 
mobility would be overestimated in the lower summed score range and underestimated (but 
less so) in higher summed score ranges (Fig. 1). The impact would be more severe in the 
lower range (the range where the participants with CP tend to score) than in the higher 
range. The largest score difference (0.3 logit) corresponded to a medium effect size (0.25). 
Inspection of ICCs identified one item with a particularly notable difference, ‘I have been 
physically able to do the activities I enjoy most’. The participants with CP gave much higher 
ratings on this item than participants in the calibration sample at comparable levels of 
overall estimated ability. (Fig. 2).
Pain interference
Individual item mean scores on the Pain Interference SF varied across the samples (range of 
differences = 0.02–0.28), with some means higher and some lower in the CP sample 
compared to the calibration sample.
DIF analyses (Table II) revealed five items with significant DIF, however only two of the 
items also had wABC that exceeded the criteria ‘It was hard for me to walk one block when 
I had pain’ and ‘It was hard to stay standing when I had pain’ (wABC=0.45 for both). For 
both items, inspection of ICCs revealed that participants with CP gave higher ratings on the 
item, indicating greater perceived limitation, than participants in the calibration sample with 
the same overall level of pain interference. Comparison of the summed scores calculated 
using PROMIS parameters versus CP parameters showed score differences across most of 
the range with the largest difference (approximately 0.35 logits) at summed score 2.
Fatigue SF
The individual item means of the two groups were more similar in this domain (range of 
difference=0–0.17). Only one item had significant DIF and a relatively large wABC (0.7; 
Table II). The impact of this one item on overall differences in summed scores was quite 
small, i.e. summary score curves were almost identical across the full range of scores. 
Additional details of the analyses are provided in Tables SI–SVI (online supplementary 
information).
DISCUSSION
Documentation of intervention outcomes of children and adolescents with CP requires 
measures that accurately represent the experience of the young people. The present study 
examined one aspect of this validity question for the PROMIS Mobility, Fatigue, and Pain 
Interference SF measures. IRT-based comparison of item calibration estimates from the 
original PROMIS sample to calibration estimates from a sample of children and adolescents 
with CP revealed that some items performed differently (i.e. had significant DIF). DIF was 
most common in mobility, where four of the eight items had significantly different 
parameter estimates. Findings suggested that if PROMIS item parameters were used, the 
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summary score might overestimate the ability (perceived mobility latent trait) of children 
and adolescents with CP compared to young people without CP who obtain the same score.
There are several possible explanations for these differences. The first is that the perceived 
difficulty of certain items is greater for children and adolescents with CP because of their 
underlying movement disorder. That is, the unique impact of the movement disorder might 
alter the relative degree of difficulty in performing the particular activities described in the 
items that had DIF. This explanation fits data from two of the mobility items (stand on tip-
toes; go upstairs without holding on), where the ICCs show that the participants with CP 
tended to give lower ratings than participants in the PROMIS calibration sample with the 
same overall ability level. A second explanation is that the children and adolescents with CP 
interpret and respond differently to certain items. This could explain why the participants 
with CP gave higher ratings to two of the items with DIF (‘keep up when playing’; 
‘physically able to do activities I enjoy most’) compared to PROMIS calibration sample 
participants at the same ability level. In contrast to health conditions that have a more 
episodic impact on a child’s mobility (e.g. asthma), the impact of CP on the child’s mobility 
is consistent. Thus, children and adolescents with CP responding to an item such as ‘do 
activities I enjoy most’ are likely to reflect on the activities they typically do, i.e. that are 
within their range of ability, not on activities that are outside this range. In this case, the 
response reflects a different interpretation of the item compared with children and 
adolescents in the calibration sample. Indications that children and adolescents with CP were 
interpreting and responding differently were also described by Kratz et al.16 who analyzed 
performance of the PROMIS Mobility computerized adaptive tests in a subsample of the 
current sample with CP. These two explanations are not mutually exclusive; it is possible 
that both may affect responses to the items.
Different interpretation may also explain the two items with DIF on the Pain Interference 
scales (‘hard to stay standing’; ‘hard to walk 1 block’). On both items, the adolescent with 
CP gave higher ratings (i.e. reported more pain interference) than PROMIS participants with 
the same overall level of pain interference. Approximately 60% of the participants with CP 
either do not walk or have difficulty walking because of their motor impairment, which 
raises the question of whether their response to these items specifically reflects their degree 
of limitation caused by pain, as the scale intended, or their overall degree of movement 
limitation. These possible differences in perspective are relevant if one wants to use the 
PROMIS SFs to compare mobility and pain interference across populations because 
equivalent scores will not have the same meaning.
In contrast to results from the Mobility and Pain Interference SFs, only one item showed 
DIF on the Fatigue SF, and its impact on total score was negligible. It is possible that 
children and adolescents with CP are better able to distinguish fatigue as a transient state and 
therefore evaluate its impact on their recent daily activities in a way that is more similar to 
that of the PROMIS calibration sample. In addition, unlike the Mobility and Pain 
Interference SFs, the Fatigue items do not ask about impact of fatigue on discrete activities. 
The one movement-related item (‘do sports and exercise’) is quite broad.
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There are several options to address these measurement issues. First, cognitive interviews of 
the PROMIS SF items could help determine whether children and adolescents with CP with 
different degrees of mobility limitation or pain are interpreting items and response options in 
a similar way to participants in previous PROMIS studies. If so, results would support 
applying DIF adjustments to the Mobility and Pain Interference SFs using equating 
procedures to enable comparison across populations using the same forms and maintaining 
the same metric. This approach has been applied successfully elsewhere.17 However, if the 
cognitive interviews suggest that some other factor – such as lack of understanding or a 
different interpretation of meaning, difficulty in making the comparison implied in the item, 
or impact of other clinical factors such as vision or upper extremity limitations – is 
influencing responses, this would indicate that the responses of children and adolescents 
with CP are not reflecting the same construct, which is a validity issue.
One option to address validity concerns would be to develop a modified SF that is specific to 
CP, following a process similar to that used to develop a Fatigue SF for persons with 
multiple sclerosis.18 This process involves selecting items in the larger PROMIS item bank 
that best represent relevant activities or concerns for young people with CP, while also 
offering broad content and measurement coverage. This approach should incorporate 
cognitive interviews with children and adolescents with CP with varying degrees of 
movement limitations to examine how they interpret the potential items and select their 
responses. Research to evaluate the psychometric properties of a CP-specific PROMIS form 
with a new sample of participants with CP would be necessary.
If cognitive testing results did not support equating, or if review of the full item bank did not 
identify sufficient relevant items, another option would be to replenish the PROMIS item 
bank with additional items designed specifically to capture the experience of children and 
adolescents with CP. A modified scale with new and existing items would need to be 
calibrated and then advanced IRT linking techniques could be used to transform the CP 
calibrations to the PROMIS metric to allow direct comparison of scores.
Limitations
Findings should be interpreted in relation to study limitations. The sample with CP had a 
larger percentage of males and a smaller proportion of younger participants than the 
PROMIS calibration samples, and included 107 individuals who were above the age range 
represented in the PROMIS sample. Previous studies during the development of these SFs 
reported some DIF by age and sex,9 however most of those items were not included in the 
SFs and we did not find DIF by age or sex in our sample of children and adolescents with 
CP. Different modes of administration were used for the two CP samples, which may have 
contributed to measurement variance or score differences. Although different modes of 
administration did not affect scores for adult PROMIS mobility items,19 this may or may not 
be the case for children and adolescents with CP.
CONCLUSION
It is not clear whether summary scores on the PROMIS Mobility and Pain Interference SFs 
have the same meaning for children and adolescents with CP as for participants in the 
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PROMIS calibration sample. These results suggest that cognitive testing with current items 
would be useful to clarify whether the items in these SFs are measuring the same construct 
as intended by the developers or whether some revisions may be needed to the measures for 
the population with CP.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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What this paper adds
• Children and adolescents with CP may not interpret some items on the 
PROMIS Mobility and Pain Interference Short Forms in the same way 
as children and adolescents in the original calibration sample.
• These differences could lead to overestimation of mobility function or 
pain interference for children and adolescents with CP.
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Figure 1. 
Score differences for Mobility and Pain Interference Short Form summed scores calculated 
with Patient Reported Outcomes Measurement Information System versus cerebral palsy-
specific parameters. IRT, item response theory.
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Figure 2. 
Item characteristic curves comparison for the Mobility item ‘I have been physically able to 
do the activities I enjoy most.’ Participants in the lower range of the cerebral palsy sample 
gave higher ratings than participants in the Patient Reported Outcomes Measurement 
Information System sample at the same level of overall ability. PROMIS, Patient Reported 
Outcomes Measurement Information System; CP, cerebral palsy.
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Table I
Demographic characteristics of samples: number and percentage
PROMIS calibration samples CP sample
Mobility
items
n (%)a
Pain Interference
items
n (%)a
Fatigue
items
n (%)a
n=303
Male 2783 (47) 2708 (47) 2164 (47) 175 (58)
Female 3109 (53) 3048 (53) 2455 (53) 125 (42)
Missing 8 10 7 1
Age (mean, SD) 12.53 (2.7) 12.32 (2.7) 12.35 (2.7) 15.45 (3.2)
  8–12 3102 (53) 3059 (53) 2426 (53) 51b (17)
  13–17 2785 (47) 2694 (47) 2189 (47) 148 (49)
  18–25 0 0 0 107 (35)
  Missing 13 13 11 1
GMFCS levelc NA
Level I 105 (35)
Level II 96 (32)
Level III 49 (17)
Level IV 31 (10)
Level V 5 (2)
Unknown/missing 17 (6)
aNumber who responded to one or more of the items included in the Short Form.
bChildren younger than 8 years: Mobility and Pain Interference samples (n=2); Fatigue sample (n=3).
c
Level I, walks without limitations; II, walks with limitations; III, walks using a handheld mobility device; IV, involves wheelchair self-mobility 
with limitations, may use power wheelchair; V, is transported in a manual wheelchair. PROMIS, Patient Reported Outcomes Measurement 
Information System; CP, cerebral palsy; SD, standard deviation; GMFCS, Gross Motor Function Classification System; NA, not available.
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